Project
Start
December 2018

Asthma medication in primary care

In the Netherlands, an estimated 610,000 people suffer from asthma. In 2015, 105,400 people were irdiagnosed with asthma. Patients with asthma are mainly treated by their general practitioner. The most commonly used asthma maintenance medication is inhaled corticosteroids (ICS) and ICS in combination with long-acting beta-agonists (LABA). However, patients often experience problems with using inhalers and their adherence is often low. Because asthma is an inflammatory disease with a variable course, many patients rely mainly on their short-acting bronchodilator to control their symptoms and less on their long-acting beta-antagonists. If asthma severity increases, chronic treatment with oral corticosteroids is sometimes necessary.
This study provides insight into the use of asthma medication, adherence, and how this is related to the risk of exacerbations (prescription OCS) and asthma control for all asthma patients according to the severity of their asthma (based on GINA-class).
Funding
AstraZenica
In this project we work together with
nvt